Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.28M Buy
60,982
+709
+1% +$118K 0.01% 559
2026
Q1
$12.6M Buy
60,273
+1,579
+3% +$397K 0.02% 489
2025
Q4
$16.7M Buy
58,694
+3,099
+6% +$969K 0.03% 438
2025
Q3
$17.2M Buy
55,595
+3,406
+7% +$1.07M 0.03% 425
2025
Q2
$16.4M Buy
52,189
+3,282
+7% +$947K 0.03% 411
2025
Q1
$12.8M Buy
48,907
+6,631
+16% +$1.79M 0.03% 415
2024
Q4
$11M Buy
42,276
+26,294
+165% +$6.62M 0.03% 422
2024
Q3
$3.72M Buy
15,982
+531
+3% +$109K 0.01% 504
2024
Q2
$3.12M Buy
15,451
+12,828
+489% +$2.31M 0.01% 540
2024
Q1
$450K Sell
2,623
-25,973
-91% -$4.84M ﹤0.01% 881
2023
Q4
$6.2M Sell
28,596
-14,494
-34% -$2.49M 0.02% 494
2023
Q3
$6.87M Sell
43,090
-9,481
-18% -$2.12M 0.03% 475
2023
Q2
$15.2M Buy
52,571
+49,913
+1,878% +$15.2M 0.06% 367
2023
Q1
$848K Sell
2,658
-6,702
-72% -$1.99M ﹤0.01% 880
2022
Q4
$2.76M Sell
9,360
-40,489
-81% -$11.2M 0.01% 676
2022
Q3
$11.4M Sell
49,849
-22,354
-31% -$5.6M 0.07% 402
2022
Q2
$15.7M Buy
72,203
+22,939
+47% +$5.21M 0.08% 332
2022
Q1
$13.1M Buy
49,264
+25,244
+105% +$6.2M 0.07% 366
2021
Q4
$6.39M Sell
24,020
-7,432
-24% -$2.16M 0.03% 522
2021
Q3
$8.94M Sell
31,452
-1,879
-6% -$536K 0.04% 423
2021
Q2
$9.15M Buy
33,331
+6,637
+25% +$1.8M 0.04% 416
2021
Q1
$6.96M Sell
26,694
-1,231
-4% -$330K 0.03% 436
2020
Q4
$7.14M Sell
27,925
-3,108
-10% -$771K 0.04% 400
2020
Q3
$7.34M Buy
31,033
+18,819
+154% +$3.96M 0.04% 360
2020
Q2
$2.37M Sell
12,214
-8,679
-42% -$1.66M 0.01% 596
2020
Q1
$3.46M Buy
+20,893
New +$3.82M 0.03% 616

Other funds holding PODD

Aviva's PODD Position: Q2 2026 in Review

Aviva increased its Insulet (PODD) stake by 1.2% in Q2 2026, buying an estimated $118K and bringing the position to 60,982 shares worth $9.28M. The position accounts for 0.01% of the portfolio, ranked #559.

Aviva first reported a position in PODD in Q1 2020 and has held it in 26 quarters since. The position peaked at $17.2M in Q3 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Aviva held 60,982 shares of Insulet worth $9.28M as of Q2 2026.
  • Aviva bought 709 Insulet shares in Q2 2026, an estimated $118K.
  • Insulet made up 0.01% of Aviva's portfolio in Q2 2026, its #559 holding.
  • Aviva first reported a position in Insulet in Q1 2020 and has held it in 26 quarters since.
  • Aviva's Insulet position peaked at $17.2M in Q3 2025.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.